Anna Wilkaniec
- Molecular Biology
- Physiology top 10%
- Neurology top 10%
- Neurology top 10%
- Cellular and Molecular Neuroscience
- Co-authors
- Agata AdamczykGrzegorz A. CzapskiMagdalena Gąssowska-DobrowolskaMagdalena CieślikHenryk JęśkoAgnieszka DominiakAnna M. LenkiewiczMarcin Strawski
- Topics
- Alzheimer's disease research and treatments (8 papers)Parkinson's Disease Mechanisms and Treatments (8 papers)Tryptophan and brain disorders (6 papers)
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Anna Wilkaniec
30 papers receiving 709 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 221
- Physiology 200
- Neurology 150
- Neurology 129
- Cellular and Molecular Neuroscience 114
Countries citing papers authored by Anna Wilkaniec
This map shows the geographic impact of Anna Wilkaniec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wilkaniec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wilkaniec more than expected).
Fields of papers citing papers by Anna Wilkaniec
This network shows the impact of papers produced by Anna Wilkaniec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wilkaniec. The network helps show where Anna Wilkaniec may publish in the future.
Co-authorship network of co-authors of Anna Wilkaniec
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wilkaniec. A scholar is included among the top collaborators of Anna Wilkaniec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wilkaniec. Anna Wilkaniec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 28 | |
| 4 | 5 | |
| 5 | 7 | |
| 6 | 5 | |
| 7 | 43 | |
| 8 | 42 | |
| 9 | 98 | |
| 10 | 44 | |
| 11 | 11 | |
| 12 | 12 | |
| 13 | 12 | |
| 14 | 77 | |
| 15 | 8 | |
| 16 | 19 | |
| 17 | 54 | |
| 18 | 18 | |
| 19 | 26 | |
| 20 | 23 |
About Anna Wilkaniec
Anna Wilkaniec is a scholar working on Biological Psychiatry, Physiology and Toxicology, having authored 32 papers that have together received 710 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Tryptophan and brain disorders (6 papers). The work is most often cited by research in Biological Psychiatry (90 citations), Physiology (76 citations) and Neurology (129 citations). Anna Wilkaniec has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Agata Adamczyk, Grzegorz A. Czapski, Magdalena Gąssowska-Dobrowolska, Magdalena Cieślik, Henryk Jęśko, Agnieszka Dominiak, Anna M. Lenkiewicz, Marcin Strawski, Joanna B. Strosznajder and Ewelina Pałasz. Their work appears in journals such as FEBS Letters, International Journal of Molecular Sciences and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.